30 March 1990
COMMERCIAL ITEM DESCRIPTION
ERYTHROMYCIN ETHYLSUCCINATE FOR ORAL SUSPENSION, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-E-37354A which is cancelled.
Shall be palatable Erythromycin Ethylsuccinate for Oral Suspension, USP.
Shall be in accordance with the requirements of the USP.
Material used in manufacture shall be of a pharmaceutical grade.
Shall contain a quantity of Erythromycin Ethylsuccinate equivalent to 200 mg of Erythromycin base per 5 ml, within the applicable assay limits for the suspension.
Workmanship. The suspension shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Bottle (BT). Shall be supplied as a dry mixture, equivalent to 8 grams or Erythromycin as crystalline ethylsuccinate in a commercially available bottle with child-resistant safety closure and minimum height of 51 mm base to shoulder. The bottle shall have sufficient capacity to hold 200 ml with adequate shake space. One bottle, as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producersí own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business